Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lumbar Disc Developers Hold Their Own With Orthopedic Giants

This article was originally published in The Gray Sheet

Executive Summary

Raymedica and Interpore Cross are readying internally-developed artificial spinal disc offerings for U.S. market entry behind J&J/DePuy Acromed, Medtronic/Sofamor Danek and Synthes-Stratec - three companies competing through recent acquisitions

You may also be interested in...



Cryolife Hydrogel Technology Provides Platform For Diverse Pipeline

Atlanta-based Cryolife is preparing for human trials to support approval of its BioDisc spinal disc repair system and plans to file for an FDA investigational device exemption in the first half of 2005

Cryolife Hydrogel Technology Provides Platform For Diverse Pipeline

Atlanta-based Cryolife is preparing for human trials to support approval of its BioDisc spinal disc repair system and plans to file for an FDA investigational device exemption in the first half of 2005

Raymedica disc update

Investigational device exemption for the PDN-Solo pivotal trial is pushed back to June, due to a longer-than-expected pilot study. With patient enrollment now scheduled to start by the end of Q4, the firm anticipates receiving PMA approval in 2007, rather than the second half of 2006. The prosthetic disc nucleus device, which previously was priced in comparison to spinal fusion at $4,000, now will be priced in line with other artificial discs at $6,000 and will fall under the new CPT code for spinal arthrodesis, expected in the spring. The company anticipates selling up to 360,000 devices upon release (1"The Gray Sheet" Oct. 27, 2003, p. 25)...

Related Content

UsernamePublicRestriction

Register

OM011382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel